EBGLYSS sol inj 250 mg/2ml ser pré 2 x 2 ml
7680693440029
CH-69344
D11AH10
07.15.0.
Reimbursement limitations:
EBGLYSS.01
Dermatite atopique – adultes et adolescents de 12 ans et plus
Le traitement exige une …
1 / 3
google
Details
- Product number
- 6934401
- CPT
- -
- Packaging group
- 2
- Unit
- Fertigspritze(n)
- Composition
- lebrikizumabum 250 mg, histidinum, acidum aceticum glaciale, saccharum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 2 ml.
Articles (1)
Ebglyss 250 mg/2 ml, Injektionslösung in Fertigspritze
Injektionslösung in Fertigspritze
2
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
250.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 2101.20
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/12/2024
Authorization holder
Almirall AG
8304 Wallisellen
Authorization information
- Swissmedic authorization number
- 69344
- Drug name
- Ebglyss, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- D11AH10
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 30/08/2024
- Authorization expiration date
- 29/08/2029
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- EBGLYSS sol inj 250 mg/2ml ser pré 2 x 2 ml
- Description (DE)
- EBGLYSS Inj Lös 250 mg/2ml Fertspr 2 x 2 ml
- Market launch
- 30/08/2024
- Narcotic (BTM)
- No